176 related articles for article (PubMed ID: 17564287)
21. Cutting balloon inflation for drug-eluting stent underexpansion due to unrecognized coronary arterial calcification.
Wilson A; Ardehali R; Brinton TJ; Yeung AC; Lee DP
Cardiovasc Revasc Med; 2006; 7(3):185-8. PubMed ID: 16945827
[TBL] [Abstract][Full Text] [Related]
22. Prevention of stent thrombosis following brachytherapy and implantation of drug-eluting stents.
Derntl M; Syeda B; Beran G; Schukro C; Denk S; Glogar D
J Interv Cardiol; 2002 Dec; 15(6):477-83. PubMed ID: 12476651
[TBL] [Abstract][Full Text] [Related]
23. In-stent coronary restenosis, but not the type of stent, is associated with impaired endothelial-dependent vasodilatation.
Mizia-Stec K; Gasior Z; Haberka M; Mizia M; Chmiel A; Janowska J; Holecki M; Mielczarek M; Zahorska-Markiewicz B
Kardiol Pol; 2009 Jan; 67(1):9-17; discussion 18. PubMed ID: 19253185
[TBL] [Abstract][Full Text] [Related]
24. Debating the risks of drug-eluting stents.
Shuchman M
N Engl J Med; 2007 Jan; 356(4):325-8. PubMed ID: 17251527
[No Abstract] [Full Text] [Related]
25. [Drug-eluting stents can increase the risk of late stent thrombosis].
Skyttberg N; Linder R; Carlsson J
Lakartidningen; 2006 Sep 27-Oct 3; 103(39):2845-7. PubMed ID: 17128916
[No Abstract] [Full Text] [Related]
26. Late angiographic stent thrombosis of polymer based paclitaxel eluting stent.
Lee CH; Lim J; Low A; Tan HC; Lim YT
Heart; 2006 Apr; 92(4):551-3. PubMed ID: 16537782
[No Abstract] [Full Text] [Related]
27. A shift in the use of drug-eluting stents in Australian private hospitals.
McLean SM; Clark DJ
Med J Aust; 2008 Jan; 188(2):127. PubMed ID: 18205596
[No Abstract] [Full Text] [Related]
28. Very late thrombosis after implantation of sirolimus eluting stent.
Karvouni E; Korovesis S; Katritsis DG
Heart; 2005 Jun; 91(6):e45. PubMed ID: 15894746
[TBL] [Abstract][Full Text] [Related]
29. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
[TBL] [Abstract][Full Text] [Related]
30. Malignancy: an unrecognized risk factor for coronary stent thrombosis?
Hobson AR; McKenzie DB; Kunadian V; Purcell I; Zaman A; Dawkins KD; Curzen N
J Invasive Cardiol; 2008 Apr; 20(4):E120-3. PubMed ID: 18398242
[TBL] [Abstract][Full Text] [Related]
31. Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.
Ducrocq G; Serebruany V; Tanguay JF
Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):939-53. PubMed ID: 17867923
[TBL] [Abstract][Full Text] [Related]
32. Heart groups issue advisories for reducing drug-eluting stent risks.
Mitka M
JAMA; 2007 Feb; 297(8):797-8. PubMed ID: 17327515
[No Abstract] [Full Text] [Related]
33. Recurrent very late stent thrombosis after bare-metal stent implantation.
Saito T; Asajima H
Catheter Cardiovasc Interv; 2007 Jul; 70(1):51-3. PubMed ID: 17295327
[TBL] [Abstract][Full Text] [Related]
34. Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial.
Leon MB; Nikolsky E; Cutlip DE; Mauri L; Liberman H; Wilson H; Patterson J; Moses J; Kandzari DE;
JACC Cardiovasc Interv; 2010 Oct; 3(10):1043-50. PubMed ID: 20965463
[TBL] [Abstract][Full Text] [Related]
35. Confined late stent thrombosis following clopidogrel withdrawal in a patient with multi-segment sirolimus-eluting stent implants.
Zavalloni D; Belli G; Rossi M; Presbitero P
J Cardiovasc Med (Hagerstown); 2007 Jul; 8(7):544-6. PubMed ID: 17568291
[No Abstract] [Full Text] [Related]
36. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely.
Chhatriwalla AK; Bhatt DL
Circ Cardiovasc Interv; 2008 Dec; 1(3):217-25. PubMed ID: 20031681
[No Abstract] [Full Text] [Related]
37. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.
Unverdorben M; Vallbracht C; Cremers B; Heuer H; Hengstenberg C; Maikowski C; Werner GS; Antoni D; Kleber FX; Bocksch W; Leschke M; Ackermann H; Boxberger M; Speck U; Degenhardt R; Scheller B
EuroIntervention; 2015 Dec; 11(8):926-34. PubMed ID: 25169589
[TBL] [Abstract][Full Text] [Related]
38. [Is stent thrombosis the new Achilles heel of interventional cardiology? State of the Art clinical trials, causes and approaches for prevention].
Grumann T; Diehl P; Bode C; Moser M
Hamostaseologie; 2007 Dec; 27(5):344-50. PubMed ID: 18060244
[TBL] [Abstract][Full Text] [Related]
39. Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of single de novo coronary lesions a first-in-human analysis of a third-generation drug-eluting stent system.
Costa JR; Abizaid A; Costa R; Feres F; Tanajura LF; Abizaid A; Mattos LA; Staico R; Siqueira D; Sousa AG; Bonan R; Sousa JE
JACC Cardiovasc Interv; 2008 Oct; 1(5):545-51. PubMed ID: 19463357
[TBL] [Abstract][Full Text] [Related]
40. We can build it, but will they come?
Gilchrist IC
Catheter Cardiovasc Interv; 2011 May; 77(6):818-9. PubMed ID: 21520383
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
